Benazepril hydrochloride, >=98% (HPLC), solid

Biochem/physiol Actions

Benazepril is a long-acting angiotensin converting enzyme (ACE) inhibitor.

Features and Benefits

This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

250, 500 mg in glass bottle

Quality Level	100
InChI key	VPSRQEHTHIMDQM-FKLPMGAJSA-N
InChI	1S/C24H28N2O5.ClH/c1-2-31-24(30)20(14-12-17-8-4-3-5-9-17)25-19-15-13-18-10-6-7-11-21(18)26(23(19)29)16-22(27)28;/h3-11,19-20,25H,2,12-16H2,1H3,(H,27,28);1H/t19
Manufacturer	SIGMA-ALDRICH
Form	solid
Assay	≥98% (HPLC)